Johnson & Johnson (Pty) Ltd released details of its much-anticipated Ottava robotic surgery platform for soft-tissue procedures during the company’s virtual medical device update on 19 November.
The platform is slated to enter human clinical trials in the second half of 2022 with a possible launch expected...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?